Pulse Biosciences (PLSE) COO Liane Teplitsky Buys 2,070 Shares

What Happened
Liane Rae Teplitsky, Chief Operating Officer of Pulse Biosciences (PLSE), made two open‑market purchases totaling 2,070 shares. On 2026-08-26 she bought 1,036 shares at $48.23 each ($49,971) and on 2026-08-28 she bought 1,034 shares at $48.35 each ($49,994), for a combined outlay of $99,965. These were purchases (transaction code P), which are generally viewed as an insider buying stock rather than selling.

Key Details

• Transaction dates and prices:
  • 2026-08-26 — 1,036 shares @ $48.23 ($49,971)
  • 2026-08-28 — 1,034 shares @ $48.35 ($49,994)
• Total purchased: 2,070 shares for $99,965.
• Shares owned after transaction: Not stated in the filing.
• Filing: Form 4 filed 2026-08-28; no late filing is indicated.
• Notable footnotes from the filing:
  • F1: Purchases occurred during an open trading window and in accordance with securities laws.
  • F2: Fractional shares were rounded down to whole shares.
  • F3: Same‑day trades at the same price were aggregated on a single line.
• Transaction code: P = Purchase.

Context
These were straightforward open‑market purchases by an executive and were disclosed on the Form 4. The footnotes indicate the trades were made during an approved trading window and processed by a broker (rounded and aggregated as described), suggesting routine compliance with the company’s insider trading policy. Purchases by executives can be informative to investors, but filings do not state the insider’s motivation.